[go: up one dir, main page]

DK3148990T3 - Thiazolidinon forbindelser og anvendelse deraf til behandling af psykiatriske eller neurologiske lidelser og inflammation, især neuroinflammation - Google Patents

Thiazolidinon forbindelser og anvendelse deraf til behandling af psykiatriske eller neurologiske lidelser og inflammation, især neuroinflammation Download PDF

Info

Publication number
DK3148990T3
DK3148990T3 DK15725042.4T DK15725042T DK3148990T3 DK 3148990 T3 DK3148990 T3 DK 3148990T3 DK 15725042 T DK15725042 T DK 15725042T DK 3148990 T3 DK3148990 T3 DK 3148990T3
Authority
DK
Denmark
Prior art keywords
neuroinflammation
psychiatric
inflammation
treatment
neurological disorders
Prior art date
Application number
DK15725042.4T
Other languages
English (en)
Inventor
Jean-Louis Reymond
Simon Nicolussi
Jürg Gertsch
Original Assignee
Univ Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bern filed Critical Univ Bern
Application granted granted Critical
Publication of DK3148990T3 publication Critical patent/DK3148990T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK15725042.4T 2014-05-28 2015-05-28 Thiazolidinon forbindelser og anvendelse deraf til behandling af psykiatriske eller neurologiske lidelser og inflammation, især neuroinflammation DK3148990T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14170449 2014-05-28
EP14171024 2014-06-03
PCT/EP2015/061915 WO2015181337A1 (en) 2014-05-28 2015-05-28 Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation

Publications (1)

Publication Number Publication Date
DK3148990T3 true DK3148990T3 (da) 2022-04-11

Family

ID=54698145

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15725042.4T DK3148990T3 (da) 2014-05-28 2015-05-28 Thiazolidinon forbindelser og anvendelse deraf til behandling af psykiatriske eller neurologiske lidelser og inflammation, især neuroinflammation

Country Status (15)

Country Link
US (3) US10155754B2 (da)
EP (2) EP3148990B1 (da)
JP (1) JP6671301B2 (da)
CN (1) CN106660976B (da)
AU (2) AU2015265865C1 (da)
BR (1) BR112016027901B1 (da)
CA (1) CA2950354C (da)
DK (1) DK3148990T3 (da)
ES (1) ES2910455T3 (da)
HR (1) HRP20220490T8 (da)
MX (2) MX378165B (da)
PL (1) PL3148990T3 (da)
RS (1) RS63107B1 (da)
RU (1) RU2734253C2 (da)
WO (1) WO2015181337A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015181336A1 (en) * 2014-05-28 2015-12-03 Universität Bern Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation
WO2024240779A1 (en) 2023-05-19 2024-11-28 Universität Bern A binding site to prevent endocannabinoid cellular reuptake

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739888A (en) * 1954-03-29 1956-03-27 Eastman Kodak Co Photographic elements containing thiazolidine derivatives
US2798067A (en) * 1954-03-29 1957-07-02 Eastman Kodak Co 2-imino-4-thiazolidones and preparation
WO2004047760A2 (en) * 2002-11-22 2004-06-10 Smithkline Beecham Corporation Novel chemical compounds
US20060264424A1 (en) * 2003-08-12 2006-11-23 Tularik Inc Arylsulfonamidobenzylic compounds
EP1654380A4 (en) 2003-08-14 2009-09-09 Insight Biopharmaceuticals Ltd METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF
PL1689726T3 (pl) * 2003-11-21 2011-05-31 Actelion Pharmaceuticals Ltd Pochodne 5-(benz-(z)-ylideno)tiazolidyn-4-onu jako środki immunosupresyjne
US7928113B2 (en) * 2005-11-14 2011-04-19 University Of Southern California Integrin-binding small molecules
WO2008100977A2 (en) * 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
WO2009137133A2 (en) * 2008-02-14 2009-11-12 University Of Washington 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
ES2557314T3 (es) 2009-05-29 2016-01-25 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Dodeca-2E,4E-dieno amidas y sus usos como medicamentos y cosméticos
GB201007187D0 (en) * 2010-04-29 2010-06-09 Iti Scotland Ltd Ubiquitination modulators

Also Published As

Publication number Publication date
CA2950354A1 (en) 2015-12-03
MX2016015627A (es) 2017-05-04
US20170197952A1 (en) 2017-07-13
HRP20220490T1 (hr) 2022-05-27
BR112016027901B1 (pt) 2023-12-12
US10155754B2 (en) 2018-12-18
AU2020213369A1 (en) 2020-08-27
AU2015265865B2 (en) 2020-05-07
CA2950354C (en) 2023-10-03
AU2020213369B2 (en) 2022-09-22
CN106660976B (zh) 2019-11-26
WO2015181337A1 (en) 2015-12-03
US20190119265A1 (en) 2019-04-25
RU2734253C2 (ru) 2020-10-13
EP3148990A1 (en) 2017-04-05
US10392377B2 (en) 2019-08-27
RU2016147230A3 (da) 2018-12-25
EP3148990B1 (en) 2022-01-19
AU2015265865A1 (en) 2016-12-15
ES2910455T3 (es) 2022-05-12
RU2016147230A (ru) 2018-07-02
PL3148990T3 (pl) 2022-05-30
RS63107B1 (sr) 2022-04-29
MX378165B (es) 2025-03-10
JP2017516795A (ja) 2017-06-22
EP4011879A1 (en) 2022-06-15
CN106660976A (zh) 2017-05-10
JP6671301B2 (ja) 2020-03-25
MX2020013537A (es) 2021-02-26
AU2015265865C1 (en) 2025-01-30
US20190382397A1 (en) 2019-12-19
US10774077B2 (en) 2020-09-15
BR112016027901A2 (pt) 2017-08-22
HRP20220490T8 (hr) 2022-06-10

Similar Documents

Publication Publication Date Title
IL285114A (en) Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3261640T3 (da) 5ht-agonister til behandling af epilepsilidelser
DK3340981T3 (da) Aryl, heteroaryl og heterocykliske forbindelser til behandling af medicinske forstyrrelser
DK3307262T3 (da) Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
DK3139925T3 (da) Valbenazin-doseringssystem til behandling af hyperkinetiske bevægelsesforstyrrelser
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
LT3250210T (lt) Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
DK3192524T3 (da) Hgf præparat egnet til behandling af neurologiske lidelser
DK3256466T3 (da) 1-heterocyclyl-isochromanylforbindelser og analoger til behandling af cns-forstyrrelser
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
DK3724173T3 (da) Forbindelser til behandling af neuromuskulære lidelser
DK3157522T3 (da) Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme